Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / TytoCare Names Adam Pellegrini as CEO and

TytoCare Names Adam Pellegrini as CEO and

GrowthUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$25.0Msum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Jul 15, 2026
    Growth Round · $25.0M (disclosed)
    Insight Venture Partners (lead) via Jeff Horing
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “TytoCare Names Adam Pellegrini as CEO and Closes $25M+ Growth Round to Scale AI-First Clinical Enablement Platform”
Investors on record
1 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Jul 15, 2026
    TytoCare Names Adam Pellegrini as CEO and announced Growth Round of $25,000,000, led by Insight Partners
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company